...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith A Loser Too

Toinv - I agree with you except I didn't have such high expectations. I wanted what you said, just didn't expect it.

Share
New Message
Please login to post a reply